MarketPulse

stroke treatment

2 articles
The Motley FoolThe Motley Fool··Eric Volkman

Boston Scientific Poised for 5X Growth as Aging Demographics Drive Demand

Boston Scientific positioned to capitalize on global aging through AFib, chronic pain, and Parkinson's treatments; recent acquisitions boost stroke capabilities.
BSXPENhealthcarevaluation
GlobeNewswire Inc.GlobeNewswire Inc.··Delveinsight

Acute Ischemic Stroke Market Set for Double-Digit Growth as Novel Therapies Advance

Acute ischemic stroke market poised for significant growth through 2036, driven by novel therapies including recently approved tenecteplase and promising pipeline candidates addressing 1.8 million annual cases.
BMYCELGrAZNDMACclinical trialsmarket growth